Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

NeuroPace (NPCE) Return on Sales (2020 - 2025)

NeuroPace has reported Return on Sales over the past 6 years, most recently at 0.1% for Q4 2025.

  • Quarterly results put Return on Sales at 0.1% for Q4 2025, up 14.0% from a year ago — trailing twelve months through Dec 2025 was 0.21% (up 13.0% YoY), and the annual figure for FY2025 was 0.21%, up 13.0%.
  • Return on Sales for Q4 2025 was 0.1% at NeuroPace, up from 0.13% in the prior quarter.
  • Over the last five years, Return on Sales for NPCE hit a ceiling of 0.1% in Q4 2025 and a floor of 1.24% in Q2 2022.
  • Median Return on Sales over the past 5 years was 0.5% (2021), compared with a mean of 0.56%.
  • Biggest five-year swings in Return on Sales: tumbled -73bps in 2022 and later surged 68bps in 2023.
  • NeuroPace's Return on Sales stood at 0.97% in 2021, then rose by 12bps to 0.86% in 2022, then surged by 58bps to 0.36% in 2023, then surged by 33bps to 0.24% in 2024, then surged by 57bps to 0.1% in 2025.
  • The last three reported values for Return on Sales were 0.1% (Q4 2025), 0.13% (Q3 2025), and 0.35% (Q2 2025) per Business Quant data.